LP

Lida Pacaud, M.D.

Chief Executive Officer

Ichnos Glenmark Innovation

Roles

Chief Executive OfficeratIchnos Glenmark Innovation
Chief Medical OfficeratLegend Biotech

Therapeutic Areas

Ichnos Glenmark Innovation Pipeline

DrugIndicationPhase
ISB 2001Multiple MyelomaPhase 1b
ISB 2301Oncology (unspecified)Preclinical
GRC 65327Oncology (unspecified)Preclinical